Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses
Primary Purpose
Bowel Obstruction, Bowel Ischemia, Diverticulitis
Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
ICG-NIRF Imaging plus ingress and egress analysis
Sponsored by
About this trial
This is an interventional diagnostic trial for Bowel Obstruction focused on measuring indocyanine green, objective perfusion rate, near infrared fluorescence, anastomotic leak, image guided surgery, anastomosis, perfusion assessment
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 18
- capability of signing informed consent
- diagnosis of malignancies of the upper gastrointestinal tract (GI), or malignancies of the lower GI, or malignancies of the hepatobiliary system, refractory ulcerative colitis, or Crohn's disease, or acute, inflammatory, degenerative functional or anatomical disorders
- Surgery possible and medically indicated to the diagnosis (esophageal resection, or subtotal or total gastrectomy, or Y-Roux reconstruction, or right or left colonic interposition, or small bowel segment resection, or ileocecal resection, or colectomy, or proctectomy with restorative ileoanal pouch (one or two-stage), or left or right hemicolectomy, or sigmoid resection, or rectal resection (deep anterior resection (TAR)), or proctectomy with colo-anal anastomosis, or abdominoperineal resection, or stoma closure, or pancreaticoduodenectomy
Exclusion Criteria:
- liver disfunction (MELD score > 10)
- ICG (indocyanine green) specific exclusion criteria as per literature (intolerance to indocyanine green or sodium iodide, iodine allergy, hyperthyroidism, autonomous thyroid adenoma, focal or diffuse autonomies of the thyroid, previously badly tolerated injection of ICG)
- pregnancy or breastfeeding
Sites / Locations
- Charité Campus Benjamin FranklinRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
ICG-NIRF Imaging and objective perfusion rate
Arm Description
Intraoperatively, ICG-NIRF imaging is used to visualize the blood supply and the rate of tissue perfusion in the area of the anastomotic site. Postoperatively, an additional ingress and egress analysis at specific regions of interest is performed.
Outcomes
Primary Outcome Measures
anastomotic leak
number of patients suffering from an anastomotic leak within 30 days of operation
Secondary Outcome Measures
Operative and post-operative complications
Clavien-Dindo for complication-level classification
Length of hospital stay
length in days
Full Information
NCT ID
NCT04709445
First Posted
January 13, 2021
Last Updated
January 13, 2021
Sponsor
Charite University, Berlin, Germany
1. Study Identification
Unique Protocol Identification Number
NCT04709445
Brief Title
Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses
Official Title
Objective Perfusion Rate Assessment of Gastrointestinal Anastomoses by Inflow and Outflow Analysis of Near-infrared Fluorescence Agents
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Unknown status
Study Start Date
March 1, 2020 (Actual)
Primary Completion Date
December 2021 (Anticipated)
Study Completion Date
December 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Charite University, Berlin, Germany
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
In this prospective, non-randomized cohort study, real-time intraoperative visualization using near-infrared-fluorescence by indocyanine green injection (ICG-NIRF) is performed at two to three time points during procedures of upper GI, lower GI and hepatobiliary surgery with anastomosis formation in open or laparoscopic surgery. Postoperatively, a detailed software-based assessment of each recording is performed to determine the objective ICG-NIRF perfusion rate before and after anastomosis formation, which is then correlated with the 30 day postoperative clinical outcome including occurrence of anastomotic leak.
Detailed Description
Near-infrared-fluorescence by indocyanine green (ICG-NIRF) utilises the fluorescent property of intravenously injected indocyanine green (ICG) as an intravascular indicator of tissue and bowel perfusion.
The investigators hypothesise that ICG-NIRF is a suitable, reliable and precise method of visualisation of the blood supply and bowel perfusion in the area of gastrointestinal and hepatobiliary anastomosis formation.
In this prospective, non-randomized cohort study, the respective upper GI, lower GI or hepatobiliary procedure with anastomosis is performed according to standard of care and indication for the corresponding disease including non-malignant, malignant and inflammatory conditions. The following procedures are included in the study, in open or laparoscopic surgery, according to the surgeon's choice:
Upper GI surgery:
Esophageal resection
Subtotal or total gastrectomy with or without jejunal pouch reconstruction
Y-Roux-reconstruction
Right or left colonic interposition (iso- or antiperistaltic)
Lower GI surgery:
Jejunal or ileal segmental resection
Ileal / Ileocoecal resection
Colectomy with restorative ileal pouch formation and ileal-pouch-anal anastomosis
Left or right-sided hemicolectomy
Sigmoid resection
Rectal resections (lower anterior resection (LAR), proctectomy with colo-anal anastomosis, abdominoperineal resection)
Stoma closure
Hepatobiliary surgery:
- Pancreaticoduodenectomy
Written informed consent for participation and ICG-administration is obtained one day before surgery.
Intraoperatively, Indocyanine Green (ICG, VerDye, Diagnostic Green GmbH, Aschheim Germany, 25 mg vials) is dissolved in 5 mL sterile water to yield a 5 mg/mL concentration. It will then be administered intravenously at three consecutive time points as a bolus of 2 ml per time point at the most. The overall dose of ICG will amount to no more than 30mg of ICG per patient.
Real-time intraoperative visualization is performed with the SpectrumTM Fluorescence Imaging Platform (Quest Innovations, Middenmeer, The Netherlands) directly after each ICG injection assessing bowel perfusion at two different time points per anastomosis respectively: before and after anastomosis formation.
Postoperative NIRF-perfusion rate assessment Using the Quest Research SoftwareTM, the recordings before and after anastomosis formation will be analysed for their perfusion rate. This analysis will provide objective, quantitative data on the perfusion for a certain time frame which is determined by the length of the video recording. This data will be collected for statistical analysis and correlation with anastomotic leak as well as postoperative outcome.
Clinical data and follow-up Clinical data will be collected from all patients regarding anastomotic leak, bowel ischemia and necrosis as well as 30 day postoperative morbidity, mortality and length and cost of hospital stay.
Further data analysis will be performed using Microsoft Excel® and IBM SPSS®.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bowel Obstruction, Bowel Ischemia, Diverticulitis, Abnormality of the Gastrointestinal Tract, Symptomatic Disorders of the Gastrointestinal Tract, Stoma Ileostomy, Cancer of the Gastrointestinal Tract, Crohn Disease, Ulcerative Colitis, Familial Adenomatous Polyposis, Pancreatic Neoplasms, Hepatobiliary Neoplasm
Keywords
indocyanine green, objective perfusion rate, near infrared fluorescence, anastomotic leak, image guided surgery, anastomosis, perfusion assessment
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
This is a non-randomised prospective cohort study design.
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
ICG-NIRF Imaging and objective perfusion rate
Arm Type
Experimental
Arm Description
Intraoperatively, ICG-NIRF imaging is used to visualize the blood supply and the rate of tissue perfusion in the area of the anastomotic site. Postoperatively, an additional ingress and egress analysis at specific regions of interest is performed.
Intervention Type
Diagnostic Test
Intervention Name(s)
ICG-NIRF Imaging plus ingress and egress analysis
Intervention Description
intraoperative NIRF Imaging using the fluorescence agent ICG (indocyanine-green) before and after anastomosis formation, postoperative analysis of ingress and egress for specific regions of interest
Primary Outcome Measure Information:
Title
anastomotic leak
Description
number of patients suffering from an anastomotic leak within 30 days of operation
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Operative and post-operative complications
Description
Clavien-Dindo for complication-level classification
Time Frame
30 days
Title
Length of hospital stay
Description
length in days
Time Frame
100 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age ≥ 18
capability of signing informed consent
diagnosis of malignancies of the upper gastrointestinal tract (GI), or malignancies of the lower GI, or malignancies of the hepatobiliary system, refractory ulcerative colitis, or Crohn's disease, or acute, inflammatory, degenerative functional or anatomical disorders
Surgery possible and medically indicated to the diagnosis (esophageal resection, or subtotal or total gastrectomy, or Y-Roux reconstruction, or right or left colonic interposition, or small bowel segment resection, or ileocecal resection, or colectomy, or proctectomy with restorative ileoanal pouch (one or two-stage), or left or right hemicolectomy, or sigmoid resection, or rectal resection (deep anterior resection (TAR)), or proctectomy with colo-anal anastomosis, or abdominoperineal resection, or stoma closure, or pancreaticoduodenectomy
Exclusion Criteria:
liver disfunction (MELD score > 10)
ICG (indocyanine green) specific exclusion criteria as per literature (intolerance to indocyanine green or sodium iodide, iodine allergy, hyperthyroidism, autonomous thyroid adenoma, focal or diffuse autonomies of the thyroid, previously badly tolerated injection of ICG)
pregnancy or breastfeeding
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Benjamin Weixler, PD MD
Phone
+49 30 450 622 798
Email
benjamin.weixler@charite.de
First Name & Middle Initial & Last Name or Official Title & Degree
Leonard Lobbes, MD
Phone
+49 30 450 622 789
Email
leonard.lobbes@charite.de
Facility Information:
Facility Name
Charité Campus Benjamin Franklin
City
Berlin
ZIP/Postal Code
12203
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Benjamin Weixler, MD PD
Phone
+49 30 450 622798
Email
benjamin.weixler@charite.de
First Name & Middle Initial & Last Name & Degree
Leonard Lobbes, MD
Phone
+49 30 450 622789
Email
leonard.lobbes@charite.de
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
24075499
Citation
Kassis ES, Kosinski AS, Ross P Jr, Koppes KE, Donahue JM, Daniel VC. Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. Ann Thorac Surg. 2013 Dec;96(6):1919-26. doi: 10.1016/j.athoracsur.2013.07.119. Epub 2013 Sep 24.
Results Reference
background
PubMed Identifier
25703524
Citation
McDermott FD, Heeney A, Kelly ME, Steele RJ, Carlson GL, Winter DC. Systematic review of preoperative, intraoperative and postoperative risk factors for colorectal anastomotic leaks. Br J Surg. 2015 Apr;102(5):462-79. doi: 10.1002/bjs.9697. Epub 2015 Feb 19.
Results Reference
background
PubMed Identifier
30710314
Citation
van den Bos J, Jongen ACHM, Melenhorst J, Breukink SO, Lenaerts K, Schols RM, Bouvy ND, Stassen LPS. Near-infrared fluorescence image-guidance in anastomotic colorectal cancer surgery and its relation to serum markers of anastomotic leakage: a clinical pilot study. Surg Endosc. 2019 Nov;33(11):3766-3774. doi: 10.1007/s00464-019-06673-6. Epub 2019 Feb 1.
Results Reference
background
PubMed Identifier
29106320
Citation
van den Bos J, Al-Taher M, Schols RM, van Kuijk S, Bouvy ND, Stassen LPS. Near-Infrared Fluorescence Imaging for Real-Time Intraoperative Guidance in Anastomotic Colorectal Surgery: A Systematic Review of Literature. J Laparoendosc Adv Surg Tech A. 2018 Feb;28(2):157-167. doi: 10.1089/lap.2017.0231. Epub 2017 Nov 6.
Results Reference
background
PubMed Identifier
26968863
Citation
Degett TH, Andersen HS, Gogenur I. Indocyanine green fluorescence angiography for intraoperative assessment of gastrointestinal anastomotic perfusion: a systematic review of clinical trials. Langenbecks Arch Surg. 2016 Sep;401(6):767-75. doi: 10.1007/s00423-016-1400-9. Epub 2016 Mar 11.
Results Reference
background
Learn more about this trial
Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses
We'll reach out to this number within 24 hrs